Evidence-based treatment of allergic rhinitis.
Allergic rhinitis is an extremely common disease worldwide, affecting 10% to 50% of the population. An increasing prevalence of allergic rhinitis over the past decades and its frequent association with asthma have raised concerns about treating the disease appropriately. New knowledge of the pathophysiologic mechanisms underlying allergic inflammation of the airways has resulted in the development of newer and better therapeutic strategies. This review focuses on evidence-based treatment of allergic rhinitis, highlighting the most recent international consensus and evidence-based guidelines on allergic rhinitis.
Pawankar
R
R
Department of Otorhinolaryngology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. Pawankar_Ruby/ent@nms.ac.jp
Fokkens
W
W
D019317:Evidence-Based Medicine / Q000379:methods*; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D016896:Treatment Outcome